Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Uni-Bio Science Group Ltd. ( (HK:0690) ) has provided an announcement.
Uni-Bio Science Group Limited has proposed a final ordinary cash dividend of HKD 0.00313 per share for the financial year ended 31 December 2025, subject to shareholder approval at the annual general meeting on 26 May 2026. The ex-dividend date is set for 28 May 2026, with the book closure from 1 to 3 June, a record date of 3 June, and payment scheduled for 12 June 2026, providing shareholders with clear timelines for determining dividend entitlement.
The dividend will be paid in Hong Kong dollars through the company’s share registrar, Tricor Investor Services Limited, in Hong Kong, with no withholding tax applicable to this distribution. The announcement also reconfirms the current board structure, listing the executive, non-executive, and independent non-executive directors, underscoring continuity in corporate governance as the company returns cash to investors.
The most recent analyst rating on (HK:0690) stock is a Hold with a HK$0.13 price target. To see the full list of analyst forecasts on Uni-Bio Science Group Ltd. stock, see the HK:0690 Stock Forecast page.
More about Uni-Bio Science Group Ltd.
Uni-Bio Science Group Limited is a Hong Kong-listed company, with its shares traded under stock code 00690. The group operates in the life sciences and biotechnology sector, focusing on pharmaceutical and biopharmaceutical products for the healthcare market.
Average Trading Volume: 4,760,649
Technical Sentiment Signal: Hold
Current Market Cap: HK$679.1M
Learn more about 0690 stock on TipRanks’ Stock Analysis page.